During the past decade, University Hospital Munich conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Munich" #1 sponsor was "Apceth GmbH & Co. KG" with 1 trials, followed by "Arteriogenesis Competence Network" with 1 trials sponsored, "Azienda Ospedaliera di Padova" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "IRCCS San Raffaele" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Munich" #1 collaborator was "Foundation Cancer Research Switzerland" with 1 trials as a collaborator and "University Hospital Inselspital, Berne" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Munich" are "Acute Kidney Injury" (1 trials), "Advanced Gastrointestinal Cancer" (1 trials), "Aneurysm" (1 trials), "Aortic Valve Stenosis" (1 trials) and "BCR-ABL Positive Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "University Hospital Munich" in a lesser frequency.

Most popular intervention types in "University Hospital Munich" are "Drug" (4 trials), "Device" (2 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AG013" (1 trials), "Aspirin" (1 trials), "Clopidogrel" (1 trials), "Crystalloids, albumin, vasoconstrictors, diuretics, renal replacement therapy" (1 trials) and "Lanreotide Autogel 120 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Munich" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospital Munich". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University Hospital Munich, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Munich, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".